The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol.
Journal Information
Full Title: Oncol Lett
Abbreviation: Oncol Lett
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"This work was supported by institutional funds provided to AZD by the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán and the Instituto de Investigaciones Biomédicas de la Universidad Nacional Autónoma de México. JALM received a PhD grant (grant no. 703562) from the Consejo Nacional de Humanidades Ciencias y Tecnologías."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025